ColonSentry
Commercial- Indications
- Colorectal cancer
Company intelligence / Profile preview
GeneNews
Markham, Ontario, Canadagenenews.onepage.me ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
GeneNews has commercialized ColonSentry™, the world’s first blood-based molecular test to assess current risk for colorectal cancer. The company’s Sentinel Principle® technology enables identification of novel biomarker panels from whole blood to address unmet clinical needs across oncology and other chronic diseases. Additional products include pharmacogenomic and companion diagnostic services. The company has established international marketing agreements for its tests with partners such as Oncore Pharma and LifeX.
- Therapeutic areas
- OncologyMetabolic DisordersPsychiatryRheumatologyCardiovascular
- Modalities
- Diagnostic test (blood-based molecular diagnostics)Genomic biomarker panel developmentCompanion diagnostic services
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
JTS Health PartnersNueHealthOncore PharmaLifeX
Beyond the preview
Go deeper on GeneNews.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneNews.